Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1742-2094

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered? ; volume:11 ; number:1 ; day:5 ; month:12 ; year:2014 ; pages:1-10 ; date:12.2014
Journal of neuroinflammation ; 11, Heft 1 (5.12.2014), 1-10, 12.2014

Creator: Loeffler, David A.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12974-014-0198-z

URN: urn:nbn:de:1111-2016032336327

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Loeffler, David A.
SpringerLink (Online service)

Other Objects (12)

Intravenous immunoglobulin and Alzheimer’s disease: what now?

Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease

Alzheimer’s disease-specific transcriptomic and epigenomic changes in the tryptophan catabolic pathway

Generating genius: how an Alzheimer’s drug became considered a ‘cognitive enhancer’ for healthy individuals

The cingulate island sign within early Alzheimer’s disease-specific hypoperfusion volumes of interest is useful for differentiating Alzheimer’s disease from dementia with Lewy bodies

Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease

DNA methylation analysis on purified neurons and glia dissects age and Alzheimer’s disease-specific changes in the human cortex

Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers

Alzheimer’s Disease

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

Alzheimer

Intravenous immunoglobulin and Alzheimer’s disease: what now?

Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease

Alzheimer’s disease-specific transcriptomic and epigenomic changes in the tryptophan catabolic pathway

Generating genius: how an Alzheimer’s drug became considered a ‘cognitive enhancer’ for healthy individuals

The cingulate island sign within early Alzheimer’s disease-specific hypoperfusion volumes of interest is useful for differentiating Alzheimer’s disease from dementia with Lewy bodies

Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease

DNA methylation analysis on purified neurons and glia dissects age and Alzheimer’s disease-specific changes in the human cortex

Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers

Alzheimer’s Disease

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

Alzheimer

Intravenous immunoglobulin and Alzheimer’s disease: what now?

Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease

Alzheimer’s disease-specific transcriptomic and epigenomic changes in the tryptophan catabolic pathway

Generating genius: how an Alzheimer’s drug became considered a ‘cognitive enhancer’ for healthy individuals

The cingulate island sign within early Alzheimer’s disease-specific hypoperfusion volumes of interest is useful for differentiating Alzheimer’s disease from dementia with Lewy bodies

Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease

DNA methylation analysis on purified neurons and glia dissects age and Alzheimer’s disease-specific changes in the human cortex

Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers

Alzheimer’s Disease

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

Alzheimer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Intravenous immunoglobulin and Alzheimer’s disease: what now?

Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease

Alzheimer’s disease-specific transcriptomic and epigenomic changes in the tryptophan catabolic pathway

Generating genius: how an Alzheimer’s drug became considered a ‘cognitive enhancer’ for healthy individuals

The cingulate island sign within early Alzheimer’s disease-specific hypoperfusion volumes of interest is useful for differentiating Alzheimer’s disease from dementia with Lewy bodies

Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease

DNA methylation analysis on purified neurons and glia dissects age and Alzheimer’s disease-specific changes in the human cortex

Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers

Alzheimer’s Disease

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

Alzheimer

Alzheimer

Intravenous immunoglobulin and Alzheimer’s disease: what now?

Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease

Alzheimer’s disease-specific transcriptomic and epigenomic changes in the tryptophan catabolic pathway

Generating genius: how an Alzheimer’s drug became considered a ‘cognitive enhancer’ for healthy individuals

The cingulate island sign within early Alzheimer’s disease-specific hypoperfusion volumes of interest is useful for differentiating Alzheimer’s disease from dementia with Lewy bodies

Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease

DNA methylation analysis on purified neurons and glia dissects age and Alzheimer’s disease-specific changes in the human cortex

Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers

Alzheimer’s Disease

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

Alzheimer

Alzheimer

Intravenous immunoglobulin and Alzheimer’s disease: what now?

Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease

Alzheimer’s disease-specific transcriptomic and epigenomic changes in the tryptophan catabolic pathway

Generating genius: how an Alzheimer’s drug became considered a ‘cognitive enhancer’ for healthy individuals

The cingulate island sign within early Alzheimer’s disease-specific hypoperfusion volumes of interest is useful for differentiating Alzheimer’s disease from dementia with Lewy bodies

Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease

DNA methylation analysis on purified neurons and glia dissects age and Alzheimer’s disease-specific changes in the human cortex

Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers

Alzheimer’s Disease

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

Alzheimer

Alzheimer

Related objects

Reset password